Veritas Genetics at the forefront of genomic screening with new studies presented at the European Society of Human Genetics Conference - ESHG 2024

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

Veritas-New-Study

More Like This

Veritas Genetic participates in a groundbreaking study highlighting the importance of polygenic risk scores in the clinical management of breast cancer patients

MGI Tech Showcases Expanding Genomics Ecosystem at ESHG 2026 with New IVD Partnering Program and OEM Collaborations

Guardant Health and Collaborators to Present New Data Across the Cancer Care Continuum at ESMO 2025

PR Newswire associated0

Element Biosciences to Showcase Sequencing Innovations at the European Human Genetics Conference

Sangamo Therapeutics to Present Pre-Clinical Data Showcasing Its Epigenetic Regulation for Neurology and CAR-Treg Research at the 30th Annual Congress of the European Society of Gene & Cell Therapy (ESGCT)

PR Newswire associated0

Genomics announces next stage of global roll-out of its predictive clinical tool Health Insights - the first ever UKCA-marked and MHRA registered test that combines genetic and clinical factors to predict and prevent common diseases

PR Newswire associated0

Highlights of ESHG | Rapid AI Karyotype Total Solution From China Makes a Big Splash

PR Newswire associated0

European Wellness Leads Pioneering Down Syndrome Research at Heidelberg University